Gehlawat Virender K, Arya Vandana, Bhardwaj Harish, Vaswani Narain D, Kaushik Jaya S
Department of Pediatrics, Pt. BD Sharma PGIMS, Rohtak, Haryana, India.
Consultant Pediatrician, Noble Heart Multispeciality Hospital, Rohtak, Haryana, India.
J Family Med Prim Care. 2021 Jan;10(1):350-353. doi: 10.4103/jfmpc.jfmpc_1405_20. Epub 2021 Jan 30.
This study was intended to document the clinical profile and treatment outcome of West syndrome in children attending a tertiary care centre in Northern India.
Data were collected by a retrospective chart review of children diagnosed with West syndrome between January 2017 to January 2018. Information was recorded pertaining to the age at onset and presentation, etiology, and associated co-morbidities; results of electroencephalography (EEG) and neuroimaging; treatment given; and final outcome. The following drugs were used for treatment: ACTH ( = 7), prednisolone ( = 17), vigabatrin ( = 25), sodium valproate ( = 28), clonazepam ( = 30), and levetiracetam ( = 13) and modified Atkins diet ( = 7). The response was categorized as spasm cessation, partial improvement (>50% improvement), or no improvement.
Records of 30 children (21 boys) were analyzed. The median (IQR) age at onset was 4 (3, 6.5) months. The median (IQR) lag time to treatment was 5 (2,14) months. Eight (26%) were premature, 2 (7%) were small for gestational age, birth asphyxia in 56%, neonatal encephalopathy in 62%. EEG findings were hypsarrhythmia in 13 (43.3%) children and modified hypsarrhythmia in 9 (30%) children. MRI finding was periventricular leukomalacia (54.1%), cystic encephalomalacia (13.8%), normal MRI (20.7%) and one had arrested hydrocephalus. There was no improvement with valproate (93%), clonazepam (89%), levetiracetam (78%). Cessation of spasm was achieved with vigabatrin (28%), prednisolone (38.2%), ACTH (42.8%). Hypsarrhythmia resolved with improvement in of background and other epileptiform abnormalities in 17 children.
The present research highlights favourable response of West syndrome to oral steroids, vigabatrin and ACTH with limited role of conventional antiepileptic drugs like sodium valporate, levetiracetam and clonazepam. Primary care physician plays a vital role in early recognition and treatment of epileptic spasm.
本研究旨在记录印度北部一家三级医疗中心收治的儿童韦斯特综合征的临床特征和治疗结果。
通过回顾性图表审查收集2017年1月至2018年1月期间诊断为韦斯特综合征的儿童的数据。记录发病和就诊年龄、病因及相关合并症;脑电图(EEG)和神经影像学检查结果;所给予的治疗;以及最终结局。使用以下药物进行治疗:促肾上腺皮质激素( = 7)、泼尼松龙( = 17)、氨己烯酸( = 25)、丙戊酸钠( = 28)、氯硝西泮( = 30)、左乙拉西坦( = 13)和改良阿特金斯饮食( = 7)。反应分为痉挛停止、部分改善(改善>50%)或无改善。
分析了30名儿童(21名男孩)的记录。发病的中位(四分位间距)年龄为4(3,6.5)个月。治疗的中位(四分位间距)延迟时间为5(2,14)个月。8名(26%)为早产儿,2名(7%)小于胎龄,56%有出生窒息,62%有新生儿脑病。13名(43.3%)儿童的EEG表现为高峰节律紊乱,9名(30%)儿童为改良高峰节律紊乱。MRI表现为脑室周围白质软化(54.1%)、囊性脑软化(13.8%)。MRI正常(20.7%),1名有脑积水停止发展。丙戊酸钠(93%)、氯硝西泮(89%)、左乙拉西坦(78%)治疗无效。氨己烯酸(28%)、泼尼松龙(38.2%)、促肾上腺皮质激素(42.8%)可使痉挛停止。17名儿童的高峰节律紊乱随着背景及其他癫痫样异常的改善而消失。
本研究强调韦斯特综合征对口服类固醇、氨己烯酸和促肾上腺皮质激素反应良好,而丙戊酸钠、左乙拉西坦和氯硝西泮等传统抗癫痫药物作用有限。基层医疗医生在癫痫性痉挛的早期识别和治疗中起着至关重要的作用。